首页> 美国卫生研究院文献>Mediterranean Journal of Hematology and Infectious Diseases >Central Nervous System Involvement in Adult Acute Lymphoblastic Leukemia: Diagnostic Tools Prophylaxis and Therapy
【2h】

Central Nervous System Involvement in Adult Acute Lymphoblastic Leukemia: Diagnostic Tools Prophylaxis and Therapy

机译:成人急性淋巴细胞白血病涉及中枢神经系统:诊断工具预防和治疗。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In adult patients with acute lymphoblastic leukemia (ALL), Central Nervous System (CNS) involvement is associated with a very poor prognosis. The diagnostic assessment of this condition relies on the use of neuroradiology, conventional cytology (CC) and flow cytometry (FCM). Among these approaches, which is the gold standard it is still a matter of debate. Neuroradiology and CC have a limited sensitivity with a higher rate of false negative results. FCM demonstrated a superior sensitivity over CC, particularly when low levels of CNS infiltrating cells are present. Although prospective studies of a large series of patients are still awaited, a positive finding by FCM appears to anticipate an adverse outcome even if CC shows no infiltration. Current strategies for adult ALL CNS-directed prophylaxis or therapy involve systemic and intrathecal chemotherapy and radiation therapy. An early and frequent intrathecal injection of cytostatic combined with systemic chemotherapy is the most effective strategy to reduce the frequency of CNS involvement. In patients with CNS overt ALL, at diagnosis or upon relapse, allogeneic hematopoietic stem cell transplantation might be considered. This review discusses risk factors, diagnostic techniques for identification of CNS infiltration and modalities of prophylaxis and therapy to manage it.
机译:在成年急性淋巴细胞白血病(ALL)患者中,中枢神经系统(CNS)受累与预后很差有关。这种情况的诊断评估取决于神经放射学,常规细胞学(CC)和流式细胞仪(FCM)的使用。在这些方法(这是金本位制)中,尚有争议。神经放射学和CC的敏感性有限,假阴性结果的发生率更高。 FCM表现出优于CC的敏感性,尤其是当存在少量CNS浸润细胞时。尽管仍在等待对大量患者的前瞻性研究,但即使CC未显示浸润,FCM的阳性结果似乎也预示了不良后果。成人ALL CNS指导的预防或治疗的当前策略涉及全身和鞘内化疗和放射治疗。早期并频繁鞘内注射细胞抑制剂和全身化疗是减少中枢神经系统受累频率的最有效策略。对于中枢神经系统显性ALL患者,在诊断时或复发时,可考虑同种异体造血干细胞移植。这篇综述讨论了危险因素,识别中枢神经系统浸润的诊断技术以及预防和治疗方法。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号